return equiti ttm
anoth strong quarter sale expand oper margin plenti
reason pump impella
report fiscal second quarter revenu million year-over-
year line preliminari result announc earli januari ahead
street estim million million respect preliminari result
announc beat driven across board strength includ domest
shock/hrpci germani japan oper margin also came basi point
estim compani benefit higher impella volum
manag reiter updat sale guidanc provid releas
preliminari result earli januari expect fiscal full year revenu
million rang million million
oper margin guidanc updat rang compar
previous
despit beat continu see room upsid guidanc driven multipl
catalyst push growth higher look fiscal see opportun
expand high-risk pci hrpci shock indic prior potenti
futur expans ramp rp japanes sale japan continu track ahead
expect on-going momentum independ nation cardiogen shock
initi new product introduct optic sensor unit state impella
europ unit state
note manag reiter expect host analyst meet later calendar
year provid updat new product impella connect smartassist new clinic
data stemi potenti iq databas updat updat total market opportun
estim follow expand indic shock hrpci would
also expect analyst meet provid new thought financi metric abiom
includ thought long-term profit compani alreadi achiev fiscal
guidanc fiscal leverag compani scale
bar set high given valuat compani sustain impress
momentum across board believ manag appropri invest
busi support growth remaind fiscal share
current trade time calendar revenu estim million
believ premium warrant compani oper monopoli vastli
under-penetrated market rate stock outperform
make number cardiac-assist devic treat acut heart failur compani portfolio
highlight impella product first percutan catheter-bas cardiac assist devic
conclus stock thought
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
domest sale million came million ahead expect support strength
util adopt impella quarter ad new center present
potenti hospit though still underutil highlight re-ord rate note increas
hospit inventori impella pump compar sequenti custom ensur adequ suppli
support case
despit impress growth continu believ number driver capabl support
momentum remaind fiscal beyond specif on-going nation csi initi ncsi
continu gain momentum site enrol prior quarter help drive
awar ultim utilization/adopt impella treat shock patient clinic front
highlight patient treat iq databas on-going focu impella abil
reduc aki injuri addit public expect yearboth expect provid
last tailwind impella growth believ fiscal domest revenu million year-
over-year prove conserv
impella connect manag highlight on-going limit launch new impella connect product
allow hospit caretak receiv real-tim patient data includ nativ cardiac output
on-line smartphon tablet devic use conjunct smartassist offer custom
real-tim support alert caretak action need ensur safeti recoveri
patientssometh especi use complex case
third quarter impella connect launch hospit manag anticip
broad market roll-out expand center limit launch expect abiom
publish clinic econom data support use system support revenue-shar
model plan product abl support yet meaning chang
estim futur impella connect use see sever advantag system expect account
see better clinic econom outcom gain confid use system increas util
also believ system help becom entrench hospit system make
difficult custom switch longer term solidifi posit market innov
sale came million ahead expect driven million beat japan germani
slightli ahead estim saw underli growth year-over-year compani continu
add center focu train initi drive util overal believ intern pick
momentum believ million fiscal fourth-quart estim conserv
japan keep pump demand impella japan remain high lead strong quarter sale
million million sequenti manag report site current
approv govern center train impella use center
sequenti ahead plan though manag reiter dedic gradual launch japan
emphas proper educ train regionsometh view prudent ensur
long-term adopt still manag increas expect fiscal year japan revenu
rang million million million last quarter current model million
sale believ conserv given better-than-expect momentum date remind
japanes market consist potenti patient repres billion opportun given larg
market opportun agre manag decis ensur roll-out control time
expect launch gain traction potenti quickli market well prime train
profit despit on-going invest compani commerci initi train educ
manufactur oper margin basi point year-over-year basi point
estim larg due higher impella sale manag narrow guidanc rang full-year oper
margin estim fiscal full-year margin believ manag guidanc
achiev first half invest support higher sale second half
gross margin came basi point expect basi point year-over-year due
headwind continu roll compani optic sensor cp inventori field swap
also prove transient modest off-set benefit manufactur scale
pipelin updat highlight posit data recent stemi safeti feasibl trial
reiter pivot trial begin calendar manag note on-going discuss fda trial
design expect meet agenc next week discuss potenti final trial primari
endpoint enrol size continu posit potenti stemi indic though expect
take sever year get approv detail safeti feasibl trial see note stemi pilot studi
lack competit januari abbott resum shield ii pivot trial php percutan heart
pump use hrpci procedur shield ii trial first began enrol septemb suspend
januari follow report motor insid pump may stop intra-procedur caus hemodynam
instabl result one death follow shield ii present tct meet septemb
mani specul trial would soon resum news surpris
believ long multi-year technolog lead expans ip portfolio signific
invest develop market-lead technolog compani effort drive data train
believ similar success medic technolog compani done protect lead market
posit even competitor look enter attract market opportun believ abbott still sever year
market launch assum support clinic data best still believ anoth market entrant could help
educ clinician larg unmet need patient high risk surgeri includ receiv
surgeri turn away help grow market
also introduc fiscal estim
expect fiscal sale million year-over-year
expect fiscal ep year-over-year
newpreviouschang newpreviouschang us impella growth margin margin summari chang modelfisc import disclosur
